date,title,source
Oct-18-18,"Cytokinetics to Announce Third Quarter Results on November 1, 2018",GlobeNewswire
Nov-01-18,"Cytokinetics (CYTK) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Cytokinetics: 3Q Earnings Snapshot,Associated Press
Nov-01-18,"Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results",GlobeNewswire
Nov-05-18,Edited Transcript of CYTK earnings conference call or presentation 1-Nov-18 8:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Cytokinetics to Participate in Upcoming Investor Conferences,GlobeNewswire
Nov-20-18,Cytokinetics Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-26-18,Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND,GlobeNewswire
Nov-27-18,"Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Nov-27-18,"Cytokinetics Completes Enrollment in FORTITUDE-ALS, Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS",GlobeNewswire
Dec-03-18,"Jim Cramer Gives His Opinion On Netflix, Kraft Heinz And More",Benzinga
Dec-10-18,Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND,GlobeNewswire
Jan-04-19,"Could Cytokinetics, Incorporateds (NASDAQ:CYTK) Investor Composition Influence The Stock Price?",Simply Wall St.
